Trends Influencing Life Sciences Investments
The new commercial model
Over the past decade, the life sciences industry has faced challenging launch returns, margin pressures, and complex patient journeys. As we look ahead, we anticipate changes of even greater scope and velocity. Download this insight brief to discover how new market pressures are shaping innovative approaches and ecosystems for investors and emerging biopharmas (EBPs).
- Discover how EBPs and investors are being influenced by evolving growth potential.
- Understand the obstacles facing U.S. launches and where opportunity exists.
- Learn about the critical link between evidence generation, demand, and utilization management.
- See how the IRA is rewriting the rules of the road for the industry.
Download the insight brief.
